Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Short/Acting Psychedelics Recent news which mentions Short/Acting Psychedelics Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates October 13, 2023 Tickers CYBN DMTTF Tags DMTTF Markets CYBN From Benzinga Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety August 28, 2023 Tickers CYBN DMTTF Tags Short/Acting Psychedelics News M&A From Benzinga Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change July 05, 2023 Tickers DMTTF Tags Management News Short/Acting Psychedelics From Benzinga Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable March 08, 2023 Tickers DMTTF Tags DMT Entities Psychedelics major depressive disorder From Benzinga Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial February 15, 2023 Tickers DMTTF Tags DMTTF Top Stories Markets From Benzinga Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents February 01, 2023 Tickers DMTTF Tags Guidance Markets United States Patent and Trademark Office (USPTO) From Benzinga Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings January 25, 2023 Tickers DMTTF Tags DMT Entities Psychedelics major depressive disorder From Benzinga This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out October 31, 2022 Tickers DMT DMTTF Tags Legal Short/Acting Psychedelics News From Benzinga This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More October 19, 2022 Tickers DMTTF Tags Biotech Psychedelics Cannabis From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.